A recent study investigating the influence of obesity on IDD has identified CXCL16 as a potential diagnostic biomarker for both obesity and IDD, highlighting its role in regulating fatty acid metabolism and facilitating IDD progression (12). The gene discussed is CXCL16; the disease is intervertebral disk degenerative disorder.